Identification | Back Directory | [Name]
Tesidolumab | [CAS]
1531594-08-7 | [Synonyms]
Tesidolumab Tesidolumab (anti-Complement C5) Research Grade Tesidolumab (DHB90004) |
Hazard Information | Back Directory | [Uses]
Tesidolumab (LFG316) is a fully-human IgG1/λ anti-C5 monoclonal antibody of 143 kDa (without glycosylation). Tesidolumab (LFG316) blocks cleavage of C5 and prevents subsequent formation of the membrane attack complex[1]. | [References]
[1] Jun-Ichi Nishimura, et al. Tesidolumab (LFG316) for treatment of C5-variant patients with paroxysmal nocturnal hemoglobinuria. Haematologica. 2022 Jun 1;107(6):1483-1488. DOI:10.3324/haematol.2020.265868 |
|
Company Name: |
Biolab Reagents
|
Tel: |
18108604356 18108604356 |
Website: |
www.biolabreagent.com/ |
|